B.K. Dallaire
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 9
- CAR-T cell therapy research 4
- Lung Cancer Research Studies 1
-
- Cancer therapeutics and mechanisms 5
- Biochemical and Molecular Research 2
- Co-authors
- A.J. Grillo-López (6 shared papers)Ronald Levy (3 shared papers)Christine A. White (4 shared papers)M. S. Czuczman (3 shared papers)Diying Shen (4 shared papers)Meyer R. Heyman (1 shared paper)Michael E. Williams (1 shared paper)Isabelle Bence‐Bruckler (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Current Pharmaceutical Biotechnology (2 papers)Blood (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Immunotherapy (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
B.K. Dallaire
18 papers receiving 5.0k citations
B.K. Dallaire's Hit Papers
Peers
Comparison fields: 5 of 95
- Genetics 1.5k
- Pathology and Forensic Medicine 2.5k
- Oncology 1.8k
- Radiology, Nuclear Medicine and Imaging 1.4k
- Immunology 1.3k
Countries citing papers authored by B.K. Dallaire
This map shows the geographic impact of B.K. Dallaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.K. Dallaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.K. Dallaire more than expected).
Fields of papers citing papers by B.K. Dallaire
This network shows the impact of papers produced by B.K. Dallaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.K. Dallaire. The network helps show where B.K. Dallaire may publish in the future.
Co-authors
The 25 scholars most cited alongside B.K. Dallaire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Hit paper breakdown → | 1998 | 2249 |
| 2 | IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma Hit paper breakdown → | 1997 | 1421 |
| 3 | Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy Hit paper breakdown → | 1999 | 707 |
| 4 | Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. | 1999 | 245 |
| 5 | 2000 | 132 | |
| 6 | 1997 | 117 | |
| 7 | 1993 | 59 | |
| 8 | 1993 | 42 | |
| 9 | 1992 | 41 | |
| 10 | 1993 | 40 | |
| 11 | 1992 | 36 | |
| 12 | 1999 | 33 | |
| 13 | 1999 | 30 | |
| 14 | Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial. | 1998 | 27 |
| 15 | 2011 | 21 | |
| 16 | 2001 | 17 | |
| 17 | 1999 | 13 | |
| 18 | 1995 | 6 | |
| 19 | 1997 | 1 |
About B.K. Dallaire
B.K. Dallaire is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 19 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Cancer therapeutics and mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (4 papers), Biochemical and Molecular Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Estrogen and related hormone effects (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (2.5k citations), Oncology (1.8k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Immunology (1.3k citations). B.K. Dallaire has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include A.J. Grillo-López, Ronald Levy, Christine A. White, M. S. Czuczman, Diying Shen, Meyer R. Heyman, Michael E. Williams, Isabelle Bence‐Bruckler, Fernando Cabanillas and John Lister. Their work appears in journals such as Journal of Clinical Oncology, Current Pharmaceutical Biotechnology, Blood, Cancer Chemotherapy and Pharmacology and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.